CoChat

Effects of lorazepam on fear-potentiated startle responses in man

Graham, S. J., Scaife, J. C., Langley, R. W., Bradshaw, C. M., Szabadi, E., Xi, L., Crumley, T., Calder, N., Gottesdiener, K., Wagner, J. A. · 2005 · Journal of Psychopharmacology
Cited by 34

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Sudden intense sensory stimuli elicit a cascade of involuntary responses, including a short-latency skeletal muscular response (‘eyeblink startle response’) and longer-latency autonomic responses. These responses are enhanced when subjects anticipate an aversive event compared to periods when subjects are resting (‘fear potentiation’). It has been reported previously that the anxiolytic diazepam can suppress fear-potentiation of the eyeblink startle response in human volunteers. The present experiment aimed to confirm and extend these observations by examining the effect of another benzodiazepine, lorazepam, on the eyeblink and skinconductance components of the acoustic startle, and on fear-potentiation of these responses. Eighteen male volunteers participated in threeweekly sessions in which they received oral treatment with placebo, lorazepam (1 mg) and lorazepam (2 mg), according to a balanced three-period, crossover, double-blind design. Two hours after ingestion of the treatments, electromyographic responses of the orbicularis oculi muscle and skin conductance responses were evoked by sound pulses during alternating periods in which the threat of an electric shock (electrodes attached to the subject’s wrist) was present (THREAT) and absent (SAFE). The THREAT condition was associated with significant increase in the amplitude of the electromyographic (EMG) and skin conductance responses; there were also increases in baseline skin conductance, the number and amplitude of ‘spontaneous’ skin conductance fluctuations and self-rated anxiety. Lorazepam attenuated the effect of THREAT on self-rated anxiety and on the amplitude of the EMG response, but had no significant effect on fear-potentiation of the skin conductanceresponses. These results extend previous findings of the effect of diazepam on the fear-potentiated eyeblink startle response to lorazepam, and suggest that fear-potentiation of the later autonomic component of the startle response may be less sensitive to benzodiazepines than the fear-potentiated eyeblink response and self-rated anxiety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881105051528

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 34

  1. 10.1177/026988110101500402 · DOI
  2. Baas J M P, 1999, Psychophysiology, 36, S29
  3. 10.1177/026988119601000404 · DOI
  4. Bradley M M, 2000, Handbook of Psychophysiology, 602
  5. 10.1111/1469-8986.3720204 · doi:10.1111/1469-8986.3720204 · Paper page
  6. 10.1111/j.1469-8986.1990.tb01966.x · DOI · Paper page
  7. Davis M, 1992, The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, 255
  8. Davis M, 2000, The Amygdala, 213, 10.1093/oso/9780198505013.003.0006 · DOI · Paper page
  9. 10.1007/BF00433036 · DOI · Paper page
  10. 10.1523/JNEUROSCI.02-06-00791.1982 · DOI · Paper page
  11. 10.1016/0166-4328(93)90102-V · DOI · Paper page
  12. 10.1177/026988110101500411 · DOI
  13. 10.1177/026988110201600101 · DOI
  14. 10.1177/0269881104042615 · DOI
  15. 10.1016/S0006-3223(02)01665-7 · DOI · Paper page
  16. 10.1016/S0167-8760(97)00072-X · DOI · Paper page
  17. 10.1016/S1388-2457(03)00202-5 · DOI · Paper page
  18. Hamm A O, 1991, Psychophysiology, 28, 228
  19. 10.1016/S0167-8760(98)00063-4 · DOI
  20. Kumari V, 1996, Psychopharmacology, 132, 352
  21. 10.1176/appi.ajp.158.1.134 · DOI
  22. 10.1037/0097-7403.20.4.380 · DOI
  23. 10.1027//0269-8803.15.3.155 · DOI
  24. 10.1027//0269-8803.15.3.173 · DOI
  25. 10.1176/ajp.153.1.64 · DOI · Paper page
  26. 10.1016/0028-3908(71)90039-6 · DOI · Paper page
  27. 10.1037/0021-843X.105.1.89 · doi:10.1037/0021-843x.105.1.89
  28. 10.1177/026988110001400105 · DOI · Paper page
  29. 10.1007/s002130050948 · DOI
  30. 10.1111/1469-8986.3640453 · doi:10.1111/1469-8986.3640453 · Paper page
  31. 10.1037/0021-843X.97.4.487 · doi:10.1037/0021-843x.97.4.487 · Paper page
  32. 10.1016/S0014-2999(03)01282-2 · DOI · Paper page
  33. Winer B J, 1991, Statistical Principles in Experimental Design
  34. 10.1016/0165-0173(96)00004-5 · DOI · Paper page

Cited by

See all 34

Metadata

Authors
Graham, S. J., Scaife, J. C., Langley, R. W., Bradshaw, C. M., Szabadi, E., Xi, L., Crumley, T., Calder, N., Gottesdiener, K., & Wagner, J. A.
Venue
Journal of Psychopharmacology
Published
2005-05
Volume
19
Issue
3
Pages
249-258
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W1974003257
Cited by
34
References
12
FWCI
2.18
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of lorazepam on fear-potentiated startle responses in man. https://app.cochat.ai/papers/10.1177/0269881105051528
The paper
Graham, S. J., Scaife, J. C., Langley, R. W., Bradshaw, C. M., Szabadi, E., Xi, L., Crumley, T., Calder, N., Gottesdiener, K., & Wagner, J. A. (2005). Effects of lorazepam on fear-potentiated startle responses in man. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105051528

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.